Shares of Bloom Energy (NYSE:BE) climbed 10% on Thursday after American Electric Power (NASDAQ:AEP) disclosed a $2.65 billion ...

A Brooklyn power-broker threw another wrench into a possible $2 million theft case now on its fifth judge — by personally ...

The therapy, A2B543, will be added as an arm to the ongoing Phase I/II EVEREST-2 trial, which is testing CAR T-cell products developed using A2's Tmod platform. According to A2, the Tmod platform ...

PERFORMANCE: Overall the Nothing Phone 2 did well but was not among our top scorers. Many users will be satisfied with its performance especially if you're looking for a mid-range smartphone. Ease of ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

The global cell and gene therapy third-party logistics market size was valued at USD 1.81 billion in 2025 and is predicted to ...

Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...

In a recent review published in Experimental & Molecular Medicine, researchers examined current evidence on the reasons and implications of pancreatic beta-cell failure and its potential reversibility ...

New findings reveal promising advancements in treating relapsed mantle cell lymphoma with BCL-2 inhibitors and novel agents, ...